Blog
Structured Data Will Help You Engage With Customers, If You Stop Ignoring It
With special thanks to Hans Kaspersetz from our AI sponsor Arteric who kindly shares this blog post. Hans will be presenting at our forthcoming 2020 BioPharma eMarketing Summit this coming May 5-7 2020 in San Diego, CA. Structured Data Will Help You Engage With...
The Unimaginable Potential of AI in Healthcare Marketing
We always overestimate the change that will occur in the next two years and underestimate the change that will occur in the next 10.- Bill GatesGrowth opportunities are hard to come by without significant investment, but one major opportunity is a self-running engine...
A Healthcare Marketer’s Secret Weapon in the Voice Search Battle
With special thanks to Hans Kaspersetz from Arteric who kindly shares this blog post. Hans will be presenting and chairing at our forthcoming (and currently in production) 2020 BioPharma eMarketing Summit on May 5-7 2020 in San Diego. We’re aggressively preparing our...
Understanding the Importance of Excipient Selection for Controlled Release
Controlled delivery formulations remain one of the favored tools for advancing the lifecycle of pharmaceutical products. A traditional strategy is to initially launch multiple daily doses of an immediate-release (IR) product, then reformulate into a once-daily...
Patient Engagement & Brand Revitalization via Mobile: Case Study
With special thanks to our sponsor EngagedMedia (a division of Aptus Health) who kindly share this case study in conjunction with the 2020 BioPharma eMarketing Summit May 5-7 2020in San Diego. (The only TED-style digital marketing event for BioPharma)There’s no doubt...
Why Should you Consider Developing Controlled and Modified-Release Drug Products?
There are a number of pharmacological and economical benefits to developing controlled and modified release drug products. Following the 505(b)(2) pathway allows companies to make modest changes to an already approved drug and get continued market exclusivity for a...